Xin Lang Cai Jing·2025-10-23 03:53Core Points - Spring Medical experienced a decline of 5.11% on October 23, with a stock price of 25.43 CNY per share and a total market capitalization of 9.754 billion CNY [1] - The company specializes in the research, production, and sales of implantable orthopedic medical devices, primarily focusing on joint prosthetics and spinal implants [1] - The main revenue source for the company is medical device products, accounting for 99.89% of total revenue, with a minor contribution from other sources [1] Company Overview - Spring Medical was established on February 12, 1998, and went public on December 30, 2021 [1] - The company's products are exported to various regions, including Asia, South America, Africa, Oceania, and Europe [1] Shareholder Information - Southern Fund's Southern Medical Health Flexible Allocation Mixed A Fund (000452) entered the top ten circulating shareholders, holding 1.603 million shares, which is 0.42% of the circulating shares [2] - The fund has reported a year-to-date return of 43.9% and a one-year return of 27.37% [2] Fund Management - The fund manager of Southern Medical Health Flexible Allocation Mixed A is Cai Qiang, who has been in the position for 2 years and 131 days [3] - The total asset size of the fund is 4.213 billion CNY, with the best return during Cai's tenure being 21.91% [3]